Central nervous system tumors

Ravi D. Rao, Paul D. Brown, Caterina Giannini, Cormac O. Maher, Fredric B. Meyer, Evanthia Galanis, Bradley J Erickson, Jan Craig Buckner

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The term primary central nervous system tumors refers to a heterogeneous group of tumors characterized by their location in the central nervous system (CNS). These tumors exhibit a wide range of clinical behavior from extremely lethal (e.g., glioblastoma) to potentially curable (e.g., germ cell tumors and medulloblastomas). The occurrence of these tumors has devastating effects on patients, and their management can be major challenge to physicians. By virtue of their location, brain tumors cause a disproportionate amount of disability and pose a threat to a patient's sense of self that is unparalleled by any other disease. The currently available therapies for most primary CNS tumors have limited activity with significant toxicity. Survivors of these tumors often have significant residual neurologic and cognitive deficits that limit their functioning for the rest of their lives.

Original languageEnglish (US)
Title of host publicationOncology: An Evidence-Based Approach
PublisherSpringer New York
Pages487-505
Number of pages19
ISBN (Print)0387242910, 9780387242910
DOIs
StatePublished - 2006

Fingerprint

Central Nervous System Neoplasms
Neoplasms
Medulloblastoma
Germ Cell and Embryonal Neoplasms
Glioblastoma
Neurologic Manifestations
Brain Neoplasms
Survivors
Central Nervous System
Physicians
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rao, R. D., Brown, P. D., Giannini, C., Maher, C. O., Meyer, F. B., Galanis, E., ... Buckner, J. C. (2006). Central nervous system tumors. In Oncology: An Evidence-Based Approach (pp. 487-505). Springer New York. https://doi.org/10.1007/0-387-31056-8_34

Central nervous system tumors. / Rao, Ravi D.; Brown, Paul D.; Giannini, Caterina; Maher, Cormac O.; Meyer, Fredric B.; Galanis, Evanthia; Erickson, Bradley J; Buckner, Jan Craig.

Oncology: An Evidence-Based Approach. Springer New York, 2006. p. 487-505.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rao, RD, Brown, PD, Giannini, C, Maher, CO, Meyer, FB, Galanis, E, Erickson, BJ & Buckner, JC 2006, Central nervous system tumors. in Oncology: An Evidence-Based Approach. Springer New York, pp. 487-505. https://doi.org/10.1007/0-387-31056-8_34
Rao RD, Brown PD, Giannini C, Maher CO, Meyer FB, Galanis E et al. Central nervous system tumors. In Oncology: An Evidence-Based Approach. Springer New York. 2006. p. 487-505 https://doi.org/10.1007/0-387-31056-8_34
Rao, Ravi D. ; Brown, Paul D. ; Giannini, Caterina ; Maher, Cormac O. ; Meyer, Fredric B. ; Galanis, Evanthia ; Erickson, Bradley J ; Buckner, Jan Craig. / Central nervous system tumors. Oncology: An Evidence-Based Approach. Springer New York, 2006. pp. 487-505
@inbook{e5ac9d8126aa45a2a025f9532a6fd752,
title = "Central nervous system tumors",
abstract = "The term primary central nervous system tumors refers to a heterogeneous group of tumors characterized by their location in the central nervous system (CNS). These tumors exhibit a wide range of clinical behavior from extremely lethal (e.g., glioblastoma) to potentially curable (e.g., germ cell tumors and medulloblastomas). The occurrence of these tumors has devastating effects on patients, and their management can be major challenge to physicians. By virtue of their location, brain tumors cause a disproportionate amount of disability and pose a threat to a patient's sense of self that is unparalleled by any other disease. The currently available therapies for most primary CNS tumors have limited activity with significant toxicity. Survivors of these tumors often have significant residual neurologic and cognitive deficits that limit their functioning for the rest of their lives.",
author = "Rao, {Ravi D.} and Brown, {Paul D.} and Caterina Giannini and Maher, {Cormac O.} and Meyer, {Fredric B.} and Evanthia Galanis and Erickson, {Bradley J} and Buckner, {Jan Craig}",
year = "2006",
doi = "10.1007/0-387-31056-8_34",
language = "English (US)",
isbn = "0387242910",
pages = "487--505",
booktitle = "Oncology: An Evidence-Based Approach",
publisher = "Springer New York",

}

TY - CHAP

T1 - Central nervous system tumors

AU - Rao, Ravi D.

AU - Brown, Paul D.

AU - Giannini, Caterina

AU - Maher, Cormac O.

AU - Meyer, Fredric B.

AU - Galanis, Evanthia

AU - Erickson, Bradley J

AU - Buckner, Jan Craig

PY - 2006

Y1 - 2006

N2 - The term primary central nervous system tumors refers to a heterogeneous group of tumors characterized by their location in the central nervous system (CNS). These tumors exhibit a wide range of clinical behavior from extremely lethal (e.g., glioblastoma) to potentially curable (e.g., germ cell tumors and medulloblastomas). The occurrence of these tumors has devastating effects on patients, and their management can be major challenge to physicians. By virtue of their location, brain tumors cause a disproportionate amount of disability and pose a threat to a patient's sense of self that is unparalleled by any other disease. The currently available therapies for most primary CNS tumors have limited activity with significant toxicity. Survivors of these tumors often have significant residual neurologic and cognitive deficits that limit their functioning for the rest of their lives.

AB - The term primary central nervous system tumors refers to a heterogeneous group of tumors characterized by their location in the central nervous system (CNS). These tumors exhibit a wide range of clinical behavior from extremely lethal (e.g., glioblastoma) to potentially curable (e.g., germ cell tumors and medulloblastomas). The occurrence of these tumors has devastating effects on patients, and their management can be major challenge to physicians. By virtue of their location, brain tumors cause a disproportionate amount of disability and pose a threat to a patient's sense of self that is unparalleled by any other disease. The currently available therapies for most primary CNS tumors have limited activity with significant toxicity. Survivors of these tumors often have significant residual neurologic and cognitive deficits that limit their functioning for the rest of their lives.

UR - http://www.scopus.com/inward/record.url?scp=84892221165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892221165&partnerID=8YFLogxK

U2 - 10.1007/0-387-31056-8_34

DO - 10.1007/0-387-31056-8_34

M3 - Chapter

AN - SCOPUS:84892221165

SN - 0387242910

SN - 9780387242910

SP - 487

EP - 505

BT - Oncology: An Evidence-Based Approach

PB - Springer New York

ER -